lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed and are posted here as part of a 12-month trial. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

Short Term Outcomes and Risk Factors for Mortality in Patients with COVID-19 in Wuhan, China: A Retrospective Study

37 Pages Posted: 23 Mar 2020

See all articles by Shuai Zhang

Shuai Zhang

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Mengfei Guo

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Limin Duan

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Feng Wu

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Zhihui Wang

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Scientific Research

Juanjuan Xu

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Yanling Ma

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Zhilei Lv

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Xueyun Tan

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Shujing Zhang

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

E. Zhou

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Zhengrong Yin

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Wenjing Xiao

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Wei Geng

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Respiratory and Critical Care Medicine

Xuan Wang

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Respiratory and Critical Care Medicine

Jianchu Zhang

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Jianguo Chen

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Pharmacology

Yu Zhang

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Pharmacy

Yang Jin

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

More...

Abstract

Background: A massive outbreak of Coronavirus disease 2019 (COVID-19) hit Wuhan City, Hubei Province, China and has become a public health emergency of global concern. In this study, we aimed to describe the clinical characteristics and short-term outcomes and explored the mortality-related risk factors.

Methods: In this retrospective, single-centre, case-control study, we examined 315 consecutive patients hospitalized in Wuhan Union Hospital West Area from January 12, 2020 to February 3, 2020, for suspected or confirmed COVID-19. Patients’ data were collected by reviewing the medical records and their 28-day outcomes were followed up. Epidemiological, demographic, clinical and laboratory data were collected and analyzed to look into the differences between survivors and non-survivors and to identify the independent predictors of mortality. Finally, a nomogram scoring system was built for prognostic evaluation.

Findings: Of the 315 patients, 137 were mild and 178 were severely ill cases. As of March 2, 2020, 47 patients deceased, 200 patients were discharged from hospital and 68 patients were still hospitalized. Compared with survivors, non-survivors were older (66 years [IQR, 61-72] vs 56 years [IQR, 41-65], p = 0·001). Univariate analyses showed that a total of 21 laboratory factors differed significantly between survivors and non-survivors. CT scan revealed reticular patterns significantly more frequently observed in the non-survivors (P <0·001). Multivariate analysis exhibited that age above 57 (Hazard Ratio [HR] 2·9, 95% CI 1·03 to 8·22; p=0·045), neutrophil-to-lymphocyte ratio (NLR) higher than 8·0 (HR 4·56, 95% CI 2·25 to 9·23; p<0·0001), and lactate dehydrogenase (LDH) level over 380U/L (HR 7·68, 95% CI 2·23 to 26·44; p=0·001) were independently associated with 28-day mortality. Based on the predicting factors including age, NLR, and LDH, a nomogram scoring system for predicting the 14-day and 28-day survival probability of patients with COVID-19 was developed.

Interpretation: Our results suggest that prognosis is unfavorable for severely ill patients with COVID-19. Age, NLR, and LDH are independent predictors of 28-day mortality.

Funding Statement: This paper was supported by the State Project for Essential Drug Research and Development, China (no. 2019ZX09301001) and the National Natural Science Foundation of China (no. 81770096 and no. 81700091).

Declaration of Interests: The authors declare no competing interests.

Ethics Approval Statement: This study was approved by the ethics committee of Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Keywords: COVID-19, Survivor, Non-survivor, Independent predictor of mortality, nomagram

Suggested Citation

Zhang, Shuai and Guo, Mengfei and Duan, Limin and Wu, Feng and Wang, Zhihui and Xu, Juanjuan and Ma, Yanling and Lv, Zhilei and Tan, Xueyun and Zhang, Shujing and Zhou, E. and Yin, Zhengrong and Xiao, Wenjing and Geng, Wei and Wang, Xuan and Zhang, Jianchu and Chen, Jianguo and Zhang, Yu and Jin, Yang, Short Term Outcomes and Risk Factors for Mortality in Patients with COVID-19 in Wuhan, China: A Retrospective Study (March 6, 2020). Available at SSRN: https://ssrn.com/abstract=3551390 or http://dx.doi.org/10.2139/ssrn.3551390

Shuai Zhang

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Wuhan
China

Mengfei Guo

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Wuhan
China

Limin Duan

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Wuhan
China

Feng Wu

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Wuhan
China

Zhihui Wang

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Scientific Research

1277 Jiefang Avenue
Wuhan, Hubei 430022
China

Juanjuan Xu

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Wuhan
China

Yanling Ma

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Wuhan
China

Zhilei Lv

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Wuhan
China

Xueyun Tan

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Wuhan, 430022
China

Shujing Zhang

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Wuhan
China

E. Zhou

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Wuhan, 430022
China

Zhengrong Yin

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Wuhan, 430022
China

Wenjing Xiao

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Wuhan, 430022
China

Wei Geng

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Respiratory and Critical Care Medicine

China

Xuan Wang

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Respiratory and Critical Care Medicine

China

Jianchu Zhang

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases

Wuhan, 430022
China

Jianguo Chen

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Pharmacology ( email )

13# Hangkong Road
Wuhan, Hubei 430030
China

Yu Zhang

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Pharmacy ( email )

Wuhan, Hubei 430022
China

Yang Jin (Contact Author)

Huazhong University of Science and Technology (Formerly Tongi Medical University) - NHC Key Laboratory of Pulmonary Diseases ( email )

Wuhan
China

Click here to go to TheLancet.com

Paper statistics

Abstract Views
303
Downloads
67